However, in this context of ovarian carcinoma, multidrug resistance reversalby the shikonin/paclitaxel combination was achieved through a P-gp-independent mechanism involving ROS production (Hao et al., 2015). The gene discussed is PGP; the disease is ovarian carcinoma.